ACVR2B and cancer: Intriguingly, blocking the bioactivities of ActRIIB has been shown to reverse cancer-induced cachexia and cardiac atrophy, and this response resulted in the extended lifespan of the experimental animals even without reducing the tumor growth (Zhou et al., 2010).